Immunotherapy harnesses the ability of the immune system to fight cancer. In some solid tumors, immunotherapy is the first line of treatment. Both small-molecule targeted therapies and immunotherapies have shown good clinical results. Further, the combination of these two approaches has the potential to result in synergistic and durable outcomes in patients. Read this white paper to distill new research tools available to fight cancer with specific drug targets.